Dr Reddy’s Labs subsidiary Aurigene and Curis to initiate phase 2 trial of PDL1-VISTA inhibitor ‘CA-170’ in India
Aurigene Discovery Technologies Ltd, a wholly owned subsidiary of Dr. Reddy’s Laboratories Ltd and Curis, Inc. have announced plans to...